Medications with stronger evidence for potential interactions include: Anticoagulants (warfarin, apixaban, rivaroxaban, edoxaban, dabigatran) Antiplatelet agents (clopidogrel, aspirin) Immunosuppressants (ciclosporin, tacrolimus) Antidiabetic medications (metformin, sulfonylureas) Other theoretical interactions may occur with certain statins and antihypertensives, though clinical evidence is limited
Pros Detailed dose logging with dose history and schedules PDF export of doses, side effects, and weight for healthcare visits Multi-medication scheduling Apple Health integration Cons Tracker-first scope the broader daily journey is lighter than all-in-one apps 3
Katherine Saunders, an obesity medicine expert at Weill Cornell Medicine and co-founder of FlyteHealth, a weight-loss treatment company
But retatrutide may be even more effective , for several reasons: Glucagon receptor activation promotes hepatic fat oxidation Reduces liver fat accumulation more robustly Improves liver enzyme levels (ALT, AST) In a subgroup analysis of the retatrutide Phase 2 trial: Patients with suspected NAFLD showed a 70%+ reduction in liver fat content , measured by MRI-PDFF These effects surpassed the reductions seen with tirzepatide and semaglutide in comparable studies Another study showed that 93% of patients on the highest dose of retatrutide had 100% resolution of fatty liver